Evogene Ltd.
EVGN
$1.06
$0.010.47%
NASDAQ
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | 30.96% | -15.96% | 13.00% | 34.62% |
| Total Depreciation and Amortization | -- | -41.31% | -38.11% | -20.16% | 3.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -3,530.00% | 486.68% | 190.10% | -60.28% |
| Change in Net Operating Assets | -- | -595.00% | -162.16% | -772.89% | 64.97% |
| Cash from Operations | -- | 5.70% | -17.63% | 4.07% | 39.30% |
| Capital Expenditure | -- | 20.38% | 56.68% | 48.40% | 27.11% |
| Sale of Property, Plant, and Equipment | -- | -61.54% | -61.54% | -61.54% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 370.92% | 118.66% | 132.91% | -120.79% |
| Cash from Investing | -- | 312.05% | 106.34% | 123.63% | -127.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 6.46% | 25.73% | -5.06% | -67.09% |
| Issuance of Common Stock | -- | -25.80% | -32.72% | 2,196.64% | 56,066.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -101.75% | -101.55% | -100.83% | 4.85% |
| Cash from Financing | -- | -70.79% | -73.72% | -64.88% | 86.98% |
| Foreign Exchange rate Adjustments | -- | 80.00% | 134.76% | 107.73% | 89.72% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 33.35% | -253.59% | -24.50% | 21.55% |